Female Hair Loss in Singapore: Why It’s More Common Than Anyone Talks About
She notices it first in the shower. More hair than usual in the drain. Then in the brush. Then, on closer inspection in a bright light, the part on her scalp looks wider than it did six months ago. She searches for what’s normal. She finds she is far from alone.
Female hair loss is significantly underreported and underdiagnosed. Many women suffer in silence for years, assuming thinning hair is simply part of ageing — or blaming it on stress or diet without investigating further. Research suggests that by age 50, up to 50% of women experience some degree of hair thinning or loss [1]. In Singapore’s high-stress environment, the prevalence may be even more significant.
The good news: female hair loss is treatable. But treatment depends on identifying the cause correctly — and there are many.
The most common form of hair loss in women, female pattern hair loss (FPHL) is driven by a combination of genetic susceptibility and androgen hormone sensitivity. Unlike male pattern baldness — which typically recedes at the temples and crown — FPHL in women produces a characteristic diffuse thinning across the top of the scalp, with the frontal hairline often preserved.
The underlying mechanism involves hair follicles that are genetically sensitive to dihydrotestosterone (DHT), a derivative of testosterone. In susceptible follicles, DHT causes progressive miniaturisation — the follicle produces finer, shorter hairs over successive cycles until it eventually stops producing hair altogether.
FPHL is a chronic, progressive condition. It doesn’t resolve on its own, and it responds better to treatment the earlier it’s started.
Telogen effluvium is a temporary but often alarming form of hair loss triggered by physiological stress. The hair growth cycle has three phases: anagen (growth), catagen (transition), and telogen (resting/shedding). Under normal circumstances, 5–10% of hairs are in telogen at any time.
Significant stressors — physical or psychological — can push a much larger proportion of follicles into telogen simultaneously. Two to four months after the triggering event, this cohort of hairs sheds, producing a noticeable increase in hair fall.
Common triggers include:
- Significant weight loss or nutritional deficiency
- Surgery or serious illness
- Pregnancy and post-partum hormonal shifts
- Severe psychological stress
- Thyroid disorders
- Iron deficiency
The key feature of telogen effluvium is its temporal relationship with the triggering event — the shedding starts months after the trigger, not during it. Most cases resolve spontaneously once the trigger is removed, though recovery can take six to twelve months.
“Post-partum hair loss is one of the most common concerns I see in younger women,” says Dr. Low Chai Ling, Medical Director, SW1 Clinic. “The hair was essentially in extended growth mode during pregnancy due to oestrogen. After delivery, oestrogen drops, a large cohort of hairs enters telogen together, and three months later there’s significant shedding. It’s alarming to experience but almost always self-limiting.”
Iron deficiency is one of the most overlooked causes of hair thinning in women, particularly those with heavy menstrual cycles. Ferritin (stored iron) levels below around 30–40 µg/L are associated with hair loss even when other blood indices are normal.
Thyroid dysfunction — both hypothyroidism and hyperthyroidism — commonly produces diffuse hair thinning. TSH (thyroid-stimulating hormone) blood testing is a routine first investigation in women presenting with hair loss.
Zinc deficiency, vitamin D deficiency, and protein malnutrition can all contribute. These are assessable with blood tests and addressable with supplementation.
A proper assessment of female hair loss includes:
- — timing, pattern, associated symptoms, medications, family history
- — dermoscopic examination of the scalp to assess follicle density and miniaturisation
- — full blood count, ferritin, thyroid function, androgen levels where indicated, vitamin D, zinc
“The history is often the most diagnostically useful part,” says Dr. Lee, SW1 Clinic. “When the loss started, how it’s progressing, whether there’s a cyclical pattern, what stressors preceded it — this context guides whether we’re dealing with FPHL, telogen effluvium, or a nutritional or hormonal secondary cause. The treatment is completely different for each.”
— the most well-evidenced topical treatment for FPHL. Applied directly to the scalp, it prolongs the anagen (growth) phase and increases follicle size. Evidence supports meaningful improvement in hair density with regular use [2].
— spironolactone, cyproterone acetate, or in some patients, combined oral contraceptives with anti-androgenic progestins. These reduce DHT’s effect on susceptible follicles.
— at SW1 Clinic, uses low-level laser light to stimulate follicular activity and improve hair density. It’s a non-invasive, medication-free option for patients who want to complement topical treatment with in-clinic support.
— at SW1 Clinic, the combines targeted scalp treatments to nourish and stimulate follicles — suitable for patients with early thinning who want a maintenance and support protocol.
Addressing the underlying trigger (treating iron deficiency, managing thyroid dysfunction, reducing nutritional deficits) and supporting the recovery period. Hair loss typically stabilises and reverses as the trigger resolves.
In-clinic treatments including the Prime Follicle Ritual can support the recovery phase by optimising scalp health during regrowth.
Hair follicle loss is easier to prevent than to reverse. FPHL, in particular, progresses over years — but the transition from “some thinning” to “significant thinning” varies by individual, and treatments started earlier produce better outcomes. Once a follicle has fully miniaturised and stopped producing hair, it is much more difficult to reactivate.
Patients who notice early changes in hair density, a wider part line, or increased shedding are well-advised to seek assessment sooner rather than waiting until the change is dramatic.
Kavitha, 40, had noticed progressive thinning across the top of her scalp over three years. Family history was significant — her mother had similar thinning from her 40s.
After assessment confirming FPHL on trichoscopy and ruling out thyroid and nutritional causes, she was started on minoxidil and spironolactone alongside monthly Revage 670 laser sessions. “Six months in, the shedding had noticeably reduced and new baby hairs were visible at the part,” she said. “I wished I’d come sooner.”
Hair loss in women is common, has multiple causes, and responds to treatment — but only if the cause is correctly identified. A consultation at SW1 Clinic will provide a thorough assessment and a treatment plan tailored to your specific pattern and cause.
Book at to arrange your assessment.
[1] Birch, M. P., Messenger, J. F., & Messenger, A. G. (2001). Hair density, hair diameter and the prevalence of female pattern hair loss. , 144(2), 297–304. [2] Olsen, E. A., Dunlap, F. E., Funicella, T., et al. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of female pattern hair loss. , 47(3), 377–385. [3] Rushton, D. H. (2002). Nutritional factors and hair loss. , 27(5), 396–404.
